JO
DTIL icon

John Overdeck’s Precision BioSciences DTIL Stock Holding History

John Overdeck’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
237,863
-69,927
-23% -$492K ﹤0.01% 3050
2026
Q1 		$1.69M Buy
307,790
+168,259
+121% +$776K ﹤0.01% 2884
2025
Q4 		$580K Buy
139,531
+56,439
+68% +$320K ﹤0.01% 3226
2025
Q3 		$459K Buy
83,092
+66,729
+408% +$320K ﹤0.01% 3019
2025
Q2 		$68.7K Buy
16,363
+2,798
+21% +$13.8K ﹤0.01% 3036
2025
Q1 		$64.7K Buy
+13,565
New +$69K ﹤0.01% 3017
2024
Q1 		– Sell
-11,026
Closed -$121K – 3094
2023
Q4 		$121K Buy
+11,026
New +$119K ﹤0.01% 2923
2023
Q3 		– Sell
-2,929
Closed -$46.2K – 3010
2023
Q2 		$46.2K Buy
2,929
+2,506
+592% +$57.3K ﹤0.01% 2838
2023
Q1 		$9.56K Buy
+423
New +$13.9K ﹤0.01% 2891
2022
Q4 		– Sell
-4,224
Closed -$165K – 2865
2022
Q3 		$165K Buy
4,224
+3,821
+948% +$182K ﹤0.01% 2150
2022
Q2 		$19K Sell
403
-7,153
-95% -$420K ﹤0.01% 2412
2022
Q1 		$698K Buy
+7,556
New +$1.03M ﹤0.01% 1868
2021
Q4 		– Sell
-6,385
Closed -$2.21M – 4401
2021
Q3 		$2.21M Buy
6,385
+1,332
+26% +$451K ﹤0.01% 1897
2021
Q2 		$1.9M Buy
+5,053
New +$1.52M ﹤0.01% 1912
2020
Q4 		– Sell
-1,266
Closed -$234K – 3425
2020
Q3 		$234K Sell
1,266
-553
-30% -$110K ﹤0.01% 2729
2020
Q2 		$454K Sell
1,819
-39
-2% -$8.54K ﹤0.01% 2063
2020
Q1 		$336K Buy
+1,858
New +$486K ﹤0.01% 2209

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

John Overdeck's DTIL Position: Q2 2026 in Review

John Overdeck reduced its Precision BioSciences (DTIL) stake by 23% in Q2 2026, selling an estimated $492K and leaving 237,863 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3050.

John Overdeck first reported a position in DTIL in Q1 2020 and has held it in 17 quarters since. The position peaked at $2.21M in Q3 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • John Overdeck held 237,863 shares of Precision BioSciences worth $1.87M as of Q2 2026.
  • John Overdeck sold 69,927 Precision BioSciences shares in Q2 2026, an estimated $492K.
  • Precision BioSciences made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3050 holding.
  • John Overdeck first reported a position in Precision BioSciences in Q1 2020 and has held it in 17 quarters since.
  • John Overdeck's Precision BioSciences position peaked at $2.21M in Q3 2021.
  • 94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.